Publication

Pseudoprogression of triple-hit diffuse large B-cell lymphoma following polatuzumab vedotin-based salvage therapy

Wang, Xin
; 
McIntosh, Lacey J
; 
Selove, William
; 
Zivny, Jaroslav
; 
Cerny, Jan
Citations
Altmetric:
Authors
Wang, Xin
McIntosh, Lacey J
Selove, William
Zivny, Jaroslav
Cerny, Jan
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Division of Hematology Oncology, Department of Medicine
 Division of Gastroenterology, Department of Medicine
 Department of Pathology
 Division of Oncologic Imaging, Department of Radiology
 Department of Medicine
Document Type
Letter to the Editor
Publication Date
2021-03-15
Keywords
Hematology
 Hemic and Lymphatic Diseases
 Neoplasms
 Oncology
 Radiology
Subject Area
Collections
Radiology Publications
Show all metadata
Embargo Expiration Date
Link to Full Text
https://doi.org/10.1080/10428194.2021.1894646
Abstract

Our case highlights the importance of recognizing the atypical radiological response of patients with hematological malignancies treated with polatuzumab vedotin or other antibody-drug conjugates.

Source

Wang X, McIntosh L, Selove WJ, Zivny J, Cerny J. Pseudoprogression of triple-hit diffuse large B-cell lymphoma following polatuzumab vedotin-based salvage therapy. Leuk Lymphoma. 2021 Mar 15:1-4. doi: 10.1080/10428194.2021.1894646. Epub ahead of print. PMID: 33719894. Link to article on publisher's site

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1080/10428194.2021.1894646
Permanent Link to this Item
https://hdl.handle.net/20.500.14038/48511
PubMed ID
33719894
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources

Link to Article in PubMed

Related Resources
Repository Citation
Rights
Distribution License